Related Experiment Video
Updated: Apr 12, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Updates on Aspergillus, Pneumocystis and other opportunistic pulmonary mycoses
Jose Curbelo1, Jose María Galván1, Javier Aspa2
1Servicio de Medicina Interna, Instituto Princesa de Investigación IIS-IP, Madrid, España.
Abstract:
Mycoses are serious diseases with potentially fatal outcome. The introduction of immunosuppressive treatments and life support techniques has led to a growing prevalence of different degrees of immunosuppression. Compromised immune response is the primary risk factor for the development of opportunistic mycoses. Early diagnosis and treatment are crucial for improving prognosis. However, isolation in cultures or identification using antigen detection techniques cannot distinguish between colonization and invasive infection, and the clinical status of the patient often prevents biopsy sampling. Clinicians thus find themselves in an uncertain position, requiring them to quickly recognize clinical and radiological signs and interpret microbiological results in context. The aim of this review is to provide a general overview of the profile of patients susceptible to these infections, the role of the immune system and, in more detail, the major diagnostic developments that have gained most acceptance and recognition among the scientific community.
Insights
Fungal infections (mycoses) are dangerous, especially in immunocompromised patients. This review highlights key diagnostic advances to improve early detection and treatment of invasive fungal infections.
Area of Science:
- Medical Mycology
- Immunology
- Infectious Diseases
Background:
- Mycoses pose significant health risks, with increasing prevalence due to immunosuppressive therapies and life support.
- Compromised immune response is a primary risk factor for opportunistic fungal infections.
- Early diagnosis and treatment are critical for improving patient outcomes.
Purpose of the Study:
- To review patient profiles susceptible to mycoses.
- To elucidate the role of the immune system in fungal infections.
- To detail major accepted diagnostic developments for fungal infections.
Main Methods:
- Literature review focusing on patient susceptibility, immune response, and diagnostic advancements.
- Analysis of current diagnostic techniques and their limitations.
- Synthesis of accepted diagnostic developments in medical mycology.
Main Results:
- Identification of key patient populations at risk for invasive mycoses.
- Understanding the immunological basis of susceptibility to fungal infections.
- Overview of established and emerging diagnostic tools for mycoses.
Conclusions:
- Accurate diagnosis of mycoses remains challenging, often requiring integration of clinical, radiological, and microbiological data.
- Distinguishing colonization from invasive infection is a critical diagnostic hurdle.
- Advancements in diagnostic methods are crucial for timely and effective management of fungal infections.
More Related Videos
Related Concept Videos
Antifungal Agents
Pneumonia III: Complications and Assessment
Fungal Phylum Ascomycota
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Other Pulmonary Disorders
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

